RhinoBlaster
- Manufacturer
- JD888 LLC
- Effective date
- 2010-03-29
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 4
- Source
- full-release
- Hydrated at
- 2026-06-01 02:02:15
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Active Ingredient Purpose
Chili Pepper (capsicum annuum) 6x HPUS Sinus Decongestant
The letters HPUS indicate that this ingredient is officially included in the Homeopathic Pharmacopeia of the United States.
HOW SUPPLIED SECTION
Distributed by JD888, LLC, Scarsdale, NY 10583
Exp: 00/00
Lot: XXXXXXXX
INDICATIONS & USAGE SECTION
Uses: temporarily relieves sinus congestion from:
Allergies, Air travel dehydration, Cold symptoms, every day discomfort
WARNINGS SECTION
Warnings:
If pregnant or breastfeeding, ask a health professional before use.
Ask a doctor before use if you have:
If you have any known allergies to the ingredients in this product
Or will have any medical condition(s) and/or procedure(s) relating to nose or sinuses.
Keep Out of Reach of Children.
If swallowed, get medical help or contact a Poison Control Center right away.
Avoid spraying into eyes. If contact occurs, rinse with flowing water.
Do not share product with others.
Do not store in direct sunlight.
Do not freeze.
DOSAGE & ADMINISTRATION SECTION
Directions:
Only for use by adults and children over 12 years of age.
For mild to persistent sinus irritation and/or congestion, 2 to 3 sprays into each nostril as needed.
To combat seasonal or environmental change, use at lease twice daily (morning and bedtime).
Shake well. Remove cap and safety clip.
When using for the first time, prime pump by depressing several times.
Hold one nostril closed. Insert tip inside open nostril and press the actuator down to deliver spray.
To be used according to standard Homeopathic conditions.
INFORMATION FOR PATIENTS SECTION
Other Information
Do not use if seal is torn or broken
Retain carton for future reference on full labeling
INACTIVE INGREDIENT SECTION
Inactive Ingredients
Distilled methylsulfonylmethane (MSM), eucalyptus oil, glycerol, lemon oil, peppermint oil, molten salt*, water
*This is melted at 1832 degrees for 12 hours to enhance purity.
OTC - QUESTIONS SECTION
Questions or Comments, Or to report serious adverse events, call or write:
JD888, LLC
106 Teakettle Spout Road
Mahopac, NY 10541
914-282-0661
www.rhinoblaster.com
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
NDC 49997-356-66
New! Say "shoo" to Ah-choo!"
Rhinoblaster a natural nasal and sinus decongestant spray homeopathic
Helps relieve allergies, cold symptoms, air travel dehydration, every day discomfort
Net contents 1 fl. oz. (29.6 ml)
Rhino Blaster was developed by an herbalist as a means of relieving his own allergy symptoms and the usual every day discomfort of environmental conditions. It's a unique blend of 100% natural ingredients that soothe and comfort while bringing relief for most sinus ailments. Made in the USA. No animal testing. Rhino Blaster is a registered trademark of JD888, LLC.
Distributed by JD888, LLC, Scarsdale, NY 10583
Exp: 00/00
Lot: XXXXXXXX
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 49997-356-66 | 2019-10-21 | C162847 | 48780-1 | 956f9ecf-dfbc-621f-e053-dbdaa90a74ad | dde610a1-7254-408e-9ae7-ad00e0318a38 |
| 49997-356-88 | 2019-10-21 | C162847 | 48780-1 | 956f9ecf-dfbc-621f-e053-dbdaa90a74ad | dde610a1-7254-408e-9ae7-ad00e0318a38 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 49997-356-66 | RhinoBlaster | 30 mL in 1 CARTON | SPRAY | 30 | 4 | |
| 49997-356-88 | RhinoBlaster | 10 mL in 1 BOTTLE, SPRAY | SPRAY | 10 | 4 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Chili Pepper | ACTIVE INGREDIENT | 00UK7646FG | 4 | |
| Chili Pepper | ACTIVE MOIETY | 00UK7646FG | 4 | |
| Dimethyl Sulfone | INACTIVE INGREDIENT | 9H4PO4Z4FT | 4 | |
| Eucalyptus Oil | INACTIVE INGREDIENT | 2R04ONI662 | 4 | |
| Glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | 4 | |
| Lemon Oil | INACTIVE INGREDIENT | I9GRO824LL | 4 | |
| Peppermint Oil | INACTIVE INGREDIENT | AV092KU4JH | 4 | |
| Sodium Chloride | INACTIVE INGREDIENT | 451W47IQ8X | 4 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 4 |
Products#
Every source-derived product name is available through these pages.
- RhinoBlaster
- Nasal Spray
- Chili Pepper
- Peppermint Oil
- Lemon Oil
- Eucalyptus Oil
- Sodium Chloride
- Dimethyl Sulfone
- Glycerin
- Water
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 49997-356 | 49997-356-66, 49997-356-88 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Chili Pepper | 00UK7646FG | ACTIB |
| Peppermint Oil | AV092KU4JH | IACT |
| Lemon Oil | I9GRO824LL | IACT |
| Eucalyptus Oil | 2R04ONI662 | IACT |
| Sodium Chloride | 451W47IQ8X | IACT |
| Dimethyl Sulfone | 9H4PO4Z4FT | IACT |
| Glycerin | PDC6A3C0OX | IACT |
| Water | 059QF0KO0R | IACT |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION, CONCENTRATE / ORAL | 200 mg/1ml | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / RECTAL | 440 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / INTRAOCULAR | 320 mg | ||
| Peppermint Oil | PEPPERMINT OIL | AV092KU4JH | GUM, CHEWING / ORAL | 526 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / ORAL | 1126 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / EPIDURAL | 0.9 %w/v | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, FOR SOLUTION / INTRAPLEURAL | 226 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / EPIDURAL | 3535 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | JELLY / TOPICAL | NA | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CREAM / TOPICAL | 1720 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SUSPENSION / INTRALESIONAL | 13 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 225 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION / OPHTHALMIC | 58 mg | ||
| Peppermint Oil | PEPPERMINT OIL | AV092KU4JH | GUM, CHEWING / BUCCAL | 526 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | POWDER, DENTIFRICE / DENTAL | 0.03 mg/mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / SUBCUTANEOUS | 15 %w/v | ||
| Peppermint Oil | PEPPERMINT OIL | AV092KU4JH | SUSPENSION / ORAL | 100 mg/1ml | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION, CONCENTRATE / INTRAMUSCULAR | 0.86 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | LIQUID / ORAL | 2400 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SPRAY / NASAL | 22.3 mg/1ml | ||
| Peppermint Oil | PEPPERMINT OIL | AV092KU4JH | PASTE, DENTIFRICE / DENTAL | 49.3 %w/w | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRA-ARTERIAL | 278 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / INTRAPERITONEAL | 0.54 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | JELLY / VAGINAL | NA | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CAPSULE, COATED / ORAL | 14.21 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | TABLET, COATED / ORAL | 1 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SYRUP / ORAL | 16734 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / INTRAVASCULAR | NA | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CAPSULE, LIQUID FILLED / ORAL | 185 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / ORAL | 148 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INHALANT / RESPIRATORY (INHALATION) | 3 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | GUM, CHEWING / BUCCAL | 230 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | GEL / TRANSDERMAL | 500 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / AURICULAR (OTIC) | 25 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / DENTAL | 0.4 %w/v | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION, CONCENTRATE / SUBCUTANEOUS | 0.86 %w/v | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRABURSAL | 9 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / ENDOTRACHEAL | 7.6 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / TOPICAL | 210 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | POWDER / TOPICAL | NA | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SUSPENSION / INTRAMUSCULAR | 26 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / OPHTHALMIC | 10 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, FOR SOLUTION / INTRATHECAL | 1.35 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / OPHTHALMIC | 12 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SYSTEM / IONTOPHORESIS | 168.1 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | LIQUID / TOPICAL | 2.5 %w/w | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SUSPENSION / INTRAVENOUS | 0.9 %w/v | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRACAUDAL | 210 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / NASAL | 330 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / OPHTHALMIC | 13 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CREAM, AUGMENTED / TOPICAL | 55 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / INTRACAUDAL | 210 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | MOUTHWASH / BUCCAL | 100 mg/1ml | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | DROPS / OPHTHALMIC | 0.08 %w/w | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | POWDER, FOR SUSPENSION / ORAL | 98 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / PERINEURAL | 648 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRAVASCULAR | 0.86 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CLOTH / TOPICAL | 0.05 mg/mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | TABLET, FILM COATED / ORAL | 100 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / NASAL | 25 mg/1ml |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| b5858372-b8af-4805-b3ac-4e2c5d2152e4 | dde610a1-7254-408e-9ae7-ad00e0318a38 | 2010-03-29 | Warnings | b5858372-b8af-4805-b3ac-4e2c5d2152e4 dde610a1-7254-408e-9ae7-ad00e0318a38 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
